References
- Fucharoen S, Winichagoon P. Thalassemia in SouthEast Asia: problems and strategy for prevention and control. Southeast Asian J Trop Med Public Health. 1992; 23:647-55.1298071
- Pansuwan A, Fucharoen G, Fucharoen S, Himakhun B, Dangwiboon S. Anemia, iron deficiency and thalassemia among adolescents in Northeast Thailand: results from two independent surveys. Acta Haematol. 2011; 125:186-92.2122856510.1159/000322666
- Borgna-Pignatti C, Gamberini MR. Complications of thalassemia major and their treatment. Expert Rev Hematol. 2011; 4:353-66.2166839910.1586/ehm.11.29
- Gamberini MR, De Sanctis V, Gilli G. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre. Pediatr Endocrinol Rev. 2008; 6 Suppl 1:158-69.19337172
- Al-Rimawi HS, Jallad MF, Amarin ZO, Al Sakaan R. Pubertal evaluation of adolescent boys with β-thalassemia major and delayed puberty. Fertil Steril. 2006; 86:886-90.10.1016/j.fertnstert.2006.02.11817027358
- De Sanctis V, Roos M, Gasser T, Fortini M, Raiola G, Galati MC. Impact of long-term iron chelation therapy on growth and endocrine functions in thalassaemia. J Pediatr Endocrinol Metab. 2006; 19:471-80.16759032
- Chern JP, Lin KH, Tsai WY, Wang SC, Lu MY, Lin DT, et al. Hypogonadotropic hypogonadism and hematologic phenotype in patients with transfusiondependent beta-thalassemia. J Pediatr Hematol Oncol. 2003; 25:880-4.10.1097/00043426-200311000-00011
- Merchant RH, Shirodkar A, Ahmed J. Evaluation of growth, puberty and endocrine dysfunctions in relation to iron overload in multi transfused Indian thalassemia patients. Indian J Pediatr. 2011; 78:679-83.10.1007/s12098-010-0351-321234716
- Soliman AT, elZalabany M, Amer M, Ansari BM. Growth and pubertal development in transfusiondependent children and adolescents with thalassaemia major and sickle cell disease: a comparative study. J Trop Pediatr. 1999; 45:23-3010.1093/tropej/45.1.23
- Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004; 89:1187-93.15477202
- Shalitin S, Carmi D, Weintrob N, Phillip M, Miskin H, Kornreich L, et al. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients. Eur J Haematol. 2005; 74:93-100.1565489810.1111/j.1600-0609.2004.00371.x
- Papadimas J, Mandala E, Pados G, Kokkas B, Georgiadis G, Tarlatzis B, et al. Pituitary–testicular axis in men with β-thalassaemia major. Hum Reprod. 1996; 11:1900-4.10.1093/oxfordjournals.humrep.a0195158921062
- Bronspiegel-Weintrob N, Olivieri NF, Tyler B, Andrews DF, Freedman MH, Holland FJ. Effect of age at the start of iron chelation therapy on gonadal function in β-thalassemia major. N Engl J Med. 1990; 323:713-9.10.1056/NEJM1990091332311042388669
- Jensen CE, Tuck SM, Old J, Morris RW, Yardumian A, De Sanctis V, et al. Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with beta-thalassaemia. Eur J Haematol. 1997; 59:76-81.9293854
- Grinspon RP, Rey RA. Anti-Müllerian hormone and Sertoli cell function in paediatric male hypogonadism. Horm Res Paediatr. 2010; 73:81-92.10.1159/00027714020190544
- Grinspon RP, Loreti N, Braslavsky D, Bedecarras P, Ambao V, Gottlieb S, et al. Sertoli cell markers in the diagnosis of paediatric male hypogonadism. J Pediatr Endocrinol Metab. 2012; 25:3.
- Matuszczak E, Hermanowicz A, Debek W, Oksiuta M, Dzienis-Koronkiewicz E, Zelazowska-Rutkowska B. Serum AMH concentration as a marker evaluating gonadal function in boys operated on for unilateral cryptorchidism between 1st and 4th year of life. Endocrine. 2012; 41:334-7.2203845210.1007/s12020-011-9551-5
- Laporte S, Couto-Silva AC, Trabado S, Lemaire P, Brailly-Tabard S, Esperou H, et al. Inhibin B and anti-M llerian hormone as markers of gonadal function after hematopoietic cell transplantation during childhood. BMC Pediatr. 2011; 11:20.10.1186/1471-2431-11-20
- Guibourdenche J, Lucidarme N, Chevenne D, Rigal O, Nicolas M, Luton D, et al. Anti-Müllerian hormone levels in serum from human foetuses and children: pattern and clinical interest. Mol Cell Endocrinol. 2003; 211:55-63.1465647710.1016/j.mce.2003.09.011
- Cuny A, Trivin C, Brailly-Tabard S, Adan L, Zerah M, Sainte-Rose C, et al. Inhibin B and antimüllerian hormone as markers of gonadal function after treatment for medulloblastoma or posterior fossa ependymoma during childhood. J Pediatr. 2011; 158:1016-22.e1.10.1016/j.jpeds.2010.11.01921168856
- Canale VC, Steinherz P, New M, Erlandson M. Endocrine function in thalassemia major. Ann N Y Acad Sci. 1974; 232:333-45.436999010.1111/j.1749-6632.1974.tb20597.x